Polfa to invest zl.40 million in producing oncology drugs

"In Q1 2007 we intend to launch production of three types of pharmaceuticals in a new, convenient form of merged ampoulette and syringe. These will be:anti-allergic, anesthetic and used to treat coronary problems," said Karolina Pokorowska, spokeswoman of Polfa Warszawa. At the same time production of pills will be moved to Nowa Deba, a production facility of Sanfarm, which is a subsidiary of Polfa. Thanks to the freed capacity in Warsaw, the plant will be used for producing the first oncology drugs in Poland, which will hit the market in 2008. "We are currently designing the production line. We want to purchase necessary equipment next year. The value of investment stands at zl.40 million," said Pokorowska. (Puls Biznesu, pp. 1, 9) M.M.